Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2,6 NDA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112441908B details a novel two-stage oxidation of 2,6-DIPN to produce 2,6-NDA with ultra-low aldehyde impurities, ensuring superior polyester quality.
Novel patent CN119306612A enables high trans-selectivity. Reduces waste and cost for pharmaceutical intermediate manufacturing supply chains.